New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Seke Etet, Paul F ^a,b   Fawzi Mahomoodally, M ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c UNIVERSITY OF MAURITIUS   (Mauritius)

Author keywords

[No Author keywords available]

Indexed keywords

ADANSONIA DIGITATA EXTRACT; ANCHOMANES DIFFORMIS EXTRACT; ANTITRYPANOSOMAL AGENT; CASSYTHA EXTRACT; CHEMOKINE; CPD 0802; CYTOKINE; DB 868; EFLORNITHINE; FEXINIDAZOLE; GARDENIA ERUBESCENS EXTRACT; HYMENOCARDIA ACIDA EXTRACT; KHAYA SENEGALENSIS EXTRACT; KIGELIA AFRICANA EXTRACT; LANNEA KERSTINGII EXTRACT; LOPHIRA LANCEOLATA EXTRACT; MELARSOPROL; NIFURTIMOX; PAFURAMIDINE; PARKIA CLAPPERTIONIANA EXTRACT; PENTAMIDINE; PILIOSTIGMA RETICULATUM EXTRACT; PLANT EXTRACT; PROSOPIS AFRICANA EXTRACT; SECURIDACA LONGEPEDUNCULATA EXTRACT; STRIGA EXTRACT; SURAMIN; TERMINALIA AVICENNOIDES EXTRACT; TRYPANOSOMA VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; PLANT MEDICINAL PRODUCT; PROTOZOAL VACCINE;

AFRICAN TRYPANOSOMIASIS; AGGLUTINATION TEST; ANTIPROTOZOAL ACTIVITY; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BRAIN DISEASE; CARD AGGLUTINATION TEST FOR TRYPANOSOMIASIS; CENTRIFUGATION; CEREBROSPINAL FLUID; CHEMOTHERAPY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG DIFFUSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SCREENING; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; INFLAMMATORY INFILTRATE; LABORATORY TEST; MEDIATOR RELEASE; MEDICINAL PLANT; MINIANION EXCHANGE CENTRIFUGATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE IDENTIFICATION; PATHOGENESIS; PATIENT MONITORING; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; PROTIST LIFE CYCLE STAGE; REACTIVE ENCEPHALOPATHY; REVIEW; SCREENING TEST; TRYPANOSOMA BRUCEI; UNSPECIFIED SIDE EFFECT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; GEOGRAPHY; HOSPITALIZATION; IMMUNOLOGY; METHODOLOGY; PATHOLOGY;

PROTOZOA; TRYPANOSOMA BRUCEI;

AFRICA SOUTH OF THE SAHARA; DRUG THERAPY, COMBINATION; GEOGRAPHY; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; PROTOZOAN VACCINES; SEVERITY OF ILLNESS INDEX; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84861083929     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/343652     Document Type: Review

References (156)

1. Hide G., History of sleeping sickness in East Africa Clinical Microbiology Reviews 1999 12 1 112 125 (Pubitemid 29055956)
2. Gooding R. H., Genetic variation in tsetse flies and implications for trypanosomiasis Parasitology Today 1992 8 3 92 95
3. Fvre E. M., Coleman P. G., Welburn S. C., Maudlin I., Reanalyzing the 19001920 sleeping sickness epidemic in Uganda Emerging Infectious Diseases 2004 10 4 567 573 (Pubitemid 38420285)
4. Donelson J. E., Antigenic variation and the African trypanosome genome Acta Tropica 2003 85 3 391 404 (Pubitemid 36349562)
5. Krafsur E. S., Tsetse flies: genetics, evolution, and role as vectors Infection, Genetics and Evolution 2009 9 1 124 141
6. WHO, African trypanosomiasis (sleeping sickness) 2010 259 Geneva, Switzerland WHO
7. Simarro P. P., Jannin J., Cattand P., Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Medicine 2008 5 2, article e55
8. Cecchi G., Paone M., Franco J. R., Fvre E. M., Diarra A., Ruiz J. A., Mattioli R. C., Simarro P. P., Towards the Atlas of human African trypanosomiasis International Journal of Health Geographics 2009 8 1, article 15
9. Fvre E. M., Wissmann B. V., Welburn S. C., Lutumba P., The burden of human African Trypanosomiasis PLoS Neglected Tropical Diseases 2008 2 12, article e333
10. Rodgers J., Human African trypanosomiasis, chemotherapy and CNS disease Journal of Neuroimmunology 2009 211 1-2 16 22
11. Brun R., Blum J., Chappuis F., Burri C., Human African trypanosomiasis The Lancet 2010 375 9709 148 159
12. Berrang-Ford L., Lundine J., Breau S., Conflict and human African trypanosomiasis Social Science Medicine 2011 72 3 398 407
13. Barrett M. P., Potential new drugs for human African trypanosomiasis: some progress at last Current Opinion in Infectious Diseases 2010 23 6 603 608
14. Barrett M. P., Boykin D. W., Brun R., Tidwell R. R., Human African trypanosomiasis: pharmacological re-engagement with a neglected disease British Journal of Pharmacology 2007 152 8 1155 1171 (Pubitemid 350242432)
15. Louis F. J., Kohagne L. T., Ebo'O E. V., Simarro P. P., Organizing an active screening campaign for human African trypanosomiasis due to Trypanosoma brucei gambiense Medecine Tropicale 2008 68 1 11 16 (Pubitemid 351482248)
16. Simarro P. P., Cecchi G., Paone M., Franco J. R., Diarra A., Ruiz J. A., Fvre E. M., Courtin F., Mattioli R. C., Jannin J. G., The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases International Journal of Health Geographics 2010 9, article 57
17. Blum J., Schmid C., Burri C., Clinical aspects of 2541 patients with second stage human African trypanosomiasis Acta Tropica 2006 97 1 55 64 (Pubitemid 41758517)
18. Bisser S., Ouwe-Missi-Oukem-Boyer O. N., Toure F. S., Taoufiq Z., Bouteille B., Buguet A., Mazier D., Harbouring in the brain: a focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis International Journal for Parasitology 2006 36 5 529 540 (Pubitemid 43674513)
19. Schultzberg M., Ambatsis M., Samuelsson E. B., Kristensson K., Van M. N., Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia Journal of Neuroscience Research 1988 21 1 56 61 (Pubitemid 19020952)
20. Enanga B., Burchmore R. J., Stewart M. L., Barrett M. P., Sleeping sickness and the brain Cellular and Molecular Life Sciences 2002 59 5 845 858 (Pubitemid 34628245)
21. Kennedy P. G., Diagnostic and neuropathogenesis issues in human African trypanosomiasis International Journal for Parasitology 2006 36 5 505 512
22. Balasegaram M., Harris S., Checchi F., Ghorashian S., Hamel C., Karunakara U., Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo Bulletin of the World Health Organization 2006 84 10 783 791 (Pubitemid 44610113)
23. Kennedy P. G., Human African trypanosomiasis-neurological aspects Journal of Neurology 2006 253 4 411 416 (Pubitemid 43965604)
24. Chappuis F., Stivanello E., Adams K., Kidane S., Pittet A., Bovier P. A., Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in Southern Sudan American Journal of Tropical Medicine and Hygiene 2004 71 3 313 317 (Pubitemid 39223507)
25. Bscher P., Mumba N. D., Kaboré J., Lejon V., Robays J., Jamonneau V., Bebronne N., Van Der Veken W., Biéler S., Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging PLoS Neglected Tropical Diseases 2009 3 11, article e471
26. Jamonneau V., Bucheton B., Kaboré J., Ilboudo H., Camara O., Courtin F., Solano P., Kaba D., Kambire R., Lingue K., Camara M., Baelmans R., Lejon V., Buscher P., Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa PLoS Neglected Tropical Diseases 2010 4 12, article e917 1 8
27. Radwanska M., Emerging trends in the diagnosis of Human African Trypanosomiasis Parasitology 2010 137 14 1977 1986
28. Verstrepen K. J., Fink G. R., Genetic and epigenetic mechanisms underlying cell-surface variability in protozoa and fungi Annual Review of Genetics 2009 43 1 24
29. Black S. J., Guirnalda P., Frenkel D., Haynes C., Bockstal V., Induction and regulation of Trypanosoma brucei VSG-specific antibody responses Parasitology 2010 137 14 2041 2049
30. Deborggraeve S., Claes F., Laurent T., Mertens P., Leclipteux T., Dujardin J. C., Herdewijn P., Bscher P., Molecular dipstick test for diagnosis of sleeping sickness Journal of Clinical Microbiology 2006 44 8 2884 2889 (Pubitemid 44228585)
31. Balasegaram M., Harris S., Checchi F., Hamel C., Karunakara U., Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo Bulletin of the World Health Organization 2006 84 10 777 782 (Pubitemid 44610112)
32. Kennedy P. G., The continuing problem of human African trypanosomiasis (sleeping sickness) Annals of Neurology 2008 64 2 116 126
33. Deborggraeve S., Bscher P., Molecular diagnostics for sleeping sickness: what is the benefit for the patient? The Lancet Infectious Diseases 2010 10 6 433 439
34. Matovu E., Kuepfer I., Boobo A., Kibona S., Burri C., Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood Journal of Clinical Microbiology 2010 48 6 2087 2090
35. Woo P., Soltys M. A., The effect of suramin on blood and tissue forms of Trypanosoma brucei and Trypanosoma rhodesiense Annals of Tropical Medicine and Parasitology 1971 65 4 465 469
36. Bailey H. H., Gipp J. J., Mulcahy R. T., Increased expression of -glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity Cancer Letters 1994 87 2 163 170
37. Lutumba P., Makieya E., Shaw A., Meheus F., Boelaert M., Human African trypanosomiasis in a rural community, Democratic Republic of Congo Emerging Infectious Diseases 2007 13 2 248 254 (Pubitemid 46193168)
38. Hasker E., Lutumba P., Mumba D., Lejon V., Bscher P., Kande V., Muyembe J. J., Menten J., Robays J., Boelaert M., Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis American Journal of Tropical Medicine and Hygiene 2010 83 2 374 379
39. Mumba N. D., Lejon V., N'Siesi F. X., Boelaert M., Bscher P., Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis Tropical Medicine and International Health 2009 14 4 438 444
40. Mumba N. D., Lejon V., Pyana P., Boelaert M., Llunga M., Menten J., Mulunda J. P., Van Nieuwenhove S., Tamfum J. J.M., Bscher P., How to shorten patient follow-up after treatment for trypanosoma brucei gambiense sleeping sickness Journal of Infectious Diseases 2010 201 3 453 463
41. Matemba L. E., Fvre E. M., Kibona S. N., Picozzi K., Cleaveland S., Shaw A. P., Welburn S. C., Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania PLoS Neglected Tropical Diseases 2010 4 11, article e868
42. Matovu E., Mugasa C. M., Ekangu R. A., Deborggraeve S., Lubega G. W., Laurent T., Schoone G. J., Schallig H. D., Bscher P., Phase II evaluation of sensitivity and specificity of PCR and NASBA Followed by Oligochromatography for Diagnosis of Human African Trypanosomiasis in Clinical Samples from D.R. Congo and Uganda PLoS Neglected Tropical Diseases 2010 4 7, article e737
43. Lejon V., Roger I., Mumba N. D., Menten J., Robays J., N'Siesi F. X., Bisser S., Boelaert M., Bscher P., Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis Clinical Infectious Diseases 2008 47 1 15 22 (Pubitemid 351920581)
44. Lejon V., Ngoyi D. M., Ilunga M., Beelaert G., Maes I., Bscher P., Fransen K., Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness Journal of Clinical Microbiology 2010 48 8 2836 2839
45. Lejon V., Ngoyi D. M., Boelaert M., Bscher P., A CATT negative result after treatment for human african trypanosomiasis is no indication for cure PLoS Neglected Tropical Diseases 2010 4 1, article e590
46. Koffi M., Solano P., Denizot M., Courtin D., Garcia A., Lejon V., Bscher P., Cuny G., Jamonneau V., Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Tropica 2006 98 2 183 188 (Pubitemid 44208725)
47. WHO, Control and surveillance of African trypanosomiasis WHO Technical Report Series 1998 881 1 113
48. Hainard A., Tiberti N., Robin X., Lejon V., Ngoyi D. M., Matovu E., Enyaru J. C., Fouda C., Ndung'u J. M., Lisacek F., Mller M., Turck N., Sanchez J. C., A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients PLoS Neglected Tropical Diseases 2009 3 6, article e459
49. WHO, Global Plan to Combat Neglected Tropical Diseases 20082015 2007 Geneva, Switzerland WHO. WHO/CDS/NTD/2007.3
50. Thuita J. K., Kagira J. M., Mwangangi D., Matovu E., Turner C. M., Masiga D., Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis PLoS Neglected Tropical Diseases 2008 2 5, article e238
51. Rodgers J., Stone T. W., Barrett M. P., Bradley B., Kennedy P. G., Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis Brain 2009 132 5 1259 1267
52. Ngotho M., Kagira J. M., Jensen H. E., Karanja S. M., Farah I. O., Hau J., Immunospecific immunoglobulins and IL-10 as markers for trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys Tropical Medicine and International Health 2009 14 7 736 747
53. Kennedy P. G., Human African trypanosomiasis of the CNS: current issues and challenges Journal of Clinical Investigation 2004 113 4 496 504 (Pubitemid 38542496)
54. Saunders N. R., Ek C. J., Habgood M. D., Dziegielewska K. M., Barriers in the brain: a renaissance? Trends in Neurosciences 2008 31 6 279 286
55. Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier Neurobiology of Disease 2010 37 1 13 25
56. Man S., Ubogu E. E., Ransohoff R. M., Inflammatory cell migration into the central nervous system: a few new twists on an old tale Brain Pathology 2007 17 2 243 250 (Pubitemid 46466143)
57. Man S., Ubogu E. E., Williams K. A., Tucky B., Callahan M. K., Ransohoff R. M., Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration Clinical and Developmental Immunology 2008 2008
58. Zeni P., Doepker E., Topphoff U. S., Huewel S., Tenenbaum T., Galla H. J., MMPs contribute to TNF- -induced alteration of the blood-cerebrospinal fluid barrier in vitro American Journal of Physiology: Cell Physiology 2007 293 3 C855 C864
59. Boda C., Courtioux B., Roques P., Pervieux L., Vatunga G., Josenando T., Ayenengoye C. R., Bouteille B., Jauberteau M. O., Bisser S., Immunophenotypic lymphocyte profiles in human African trypanosomiasis PLoS ONE 2009 4 7
60. Bouteille B., Mpandzou G., Cespuglio R., Ngampo S., Peeling R. W., Vincendeau P., Buguet A., Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field Tropical Medicine and International Health 2010 15 4 454 461
61. Masocha W., Robertson B., Rottenberg M. E., Mhlanga J., Sorokin L., Kristensson K., Cerebral vessel laminins and IFN- define Trypanosoma brucei brucei penetration of the blood-brain barrier Journal of Clinical Investigation 2004 114 5 689 694 (Pubitemid 39578759)
62. Masocha W., Rottenberg M. E., Kristensson K., Migration of African trypanosomes across the blood-brain barrier Physiology and Behavior 2007 92 1-2 110 114 (Pubitemid 47374257)
63. Sharafeldin A., Eltayeb R., Pashenkov M., Bakhiet M., Chemokines are produced in the brain early during the course of experimental African trypanosomiasis Journal of Neuroimmunology 2000 103 2 165 170 (Pubitemid 30079728)
64. MacLean L. M., Odiit M., Chisi J. E., Kennedy P. G., Sternberg J. M., Focus-specific clinical profiles in human African trypanosomiasis caused by trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases 2010 4 12, article e906 1 12
65. MacLean L., Odiit M., Sternberg J. M., Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients Transactions of the Royal Society of Tropical Medicine and Hygiene 2006 100 3 270 275 (Pubitemid 43091826)
66. Lejon V., Bscher P., Review article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up Tropical Medicine and International Health 2005 10 5 395 403 (Pubitemid 40712423)
67. Amin D. N., Ngoyi D. M., Nhkwachi G. M., Palomba M., Rottenberg M., Bscher P., Kristensson K., Masocha W., Identification of stage biomarkers for human African trypanosomiasis American Journal of Tropical Medicine and Hygiene 2010 82 6 983 990
68. Hainard A., Tiberti N., Robin X., Ngoyi D. M., Matovu E., Enyaru J. C. K., Mller M., Turck N., Ndung'u J. M., Lejon V., Sanchez J. C., Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis Tropical Medicine and International Health 2011 16 1 119 126
69. Nok A. J., Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis Parasitology Research 2003 90 1 71 79 (Pubitemid 36577873)
70. Sanderson L., Dogruel M., Rodgers J., de Koning H. P., Thomas S. A., Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein Journal of Pharmacology and Experimental Therapeutics 2009 329 3 967 977
71. Hawking F., Sen A. B., The trypanocidal action of homidium, quinapyramine and suramin British Journal of Pharmacology and Chemotherapy 1960 15 567 570
72. de Clercq E., Antiviral drug discovery: ten more compounds, and ten more stories (Part B) Medicinal Research Reviews 2009 29 4 571 610
73. Lopez E. S., Rizzo M. M., Croxatto J. O., Mazzolini G., Gallo J. E., Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization Cancer Chemotherapy and Pharmacology 2011 67 3 723 728
74. Wilkinson S. R., Kelly J. M., Trypanocidal drugs: mechanisms, resistance and new targets Expert Reviews in Molecular Medicine 2009 11 e31
75. Rusnati M., Urbinati C., Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis Current Pharmaceutical Design 2009 15 25 2946 2957
76. Lutje V., Seixas J., Kennedy A., Chemotherapy for second-stage Human African trypanosomiasis Cochrane Database of Systematic Reviews 2010 8 CD006201
77. Bray P. G., Barrett M. P., Ward S. A., de Koning H. P., Pentamidine uptake and resistance in pathogenic protozoa: past, present and future Trends in Parasitology 2003 19 5 232 239 (Pubitemid 36588598)
78. Kumar N., Gupta S., Dube A., Vyas S. P., Emerging role of vesicular carriers for therapy of visceral leishmaniasis: conventional versus novel Critical Reviews in Therapeutic Drug Carrier Systems 2010 27 6 461 507
79. Jeganathan S., Sanderson L., Dogruel M., Rodgers J., Croft S., Thomas S. A., The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers Journal of Pharmacology and Experimental Therapeutics 2011 336 2 506 515
80. Basselin M., Robert-Gero M., Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania Parasitology Research 1998 84 1 78 83 (Pubitemid 28097631)
81. Basselin M., Denise H., Coombs G. H., Barrett M. P., Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion Antimicrobial Agents and Chemotherapy 2002 46 12 3731 3738 (Pubitemid 35403244)
82. Simpson A. G., Stevens J. R., Luke J., The evolution and diversity of kinetoplastid flagellates Trends in Parasitology 2006 22 4 168 174
83. Mukherjee A., Padmanabhan P. K., Sahani M. H., Barrett M. P., Madhubala R., Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani Molecular and Biochemical Parasitology 2006 145 1 1 10 (Pubitemid 41691849)
84. Lai D. H., Hashimi H., Lun Z. R., Ayala F. J., Lukes J., Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei Proceedings of the National Academy of Sciences of the United States of America 2008 105 6 1999 2004 (Pubitemid 351439454)
85. Bridges D. J., Gould M. K., Nerima B., Mser P., Burchmore R. J., de Koning H. P., Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in african trypanosomes Molecular Pharmacology 2007 71 4 1098 1108 (Pubitemid 46457013)
86. Burri C., Chemotherapy against human African trypanosomiasis: is there a road to success? Parasitology 2010 137 14 1987 1994
87. Carter N. S., Berger B. J., Fairlamb A. H., Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen- sensitive and -resistant Trypanosoma brucei brucei Journal of Biological Chemistry 1995 270 47 28153 28157
88. Keiser J., Ericsson O., Burri C., Investigations of the metabolites of the trypanocidal drug melarsoprol Clinical Pharmacology and Therapeutics 2000 67 5 478 488 (Pubitemid 30327486)
89. Pépin J., Mpia B., Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis Transactions of the Royal Society of Tropical Medicine and Hygiene 2006 100 5 437 441 (Pubitemid 43362145)
90. Pépin J., Labbé A.-C., Mamadou-Yaya F., Mbélesso P., Mbadinga S., Deslandes S., Locas M. -C., Frost E., Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa Clinical Infectious Diseases 2010 51 7 777 784
91. Barrett M. P., Veterinary link to drug resistance in human African trypanosomiasis? Lancet 2001 358 9282 603 604 (Pubitemid 32786822)
92. Burri C., Brun R., Eflornithine for the treatment of human African trypanosomiasis Parasitology Research 2003 90 supplement 1 S49 S52
93. Schmid C., Nkunku S., Merolle A., Vounatsou P., Burri C., Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness Lancet 2004 364 9436 789 790 (Pubitemid 39165100)
94. Matovu E., Stewart M. L., Geiser F., Brun R., Mser P., Wallace L. J. M., Burchmore R. J., Enyaru J. C. K., Barrett M. P., Kaminsky R., Seebeck T., De Koning H. P., Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei Eukaryotic Cell 2003 2 5 1003 1008 (Pubitemid 37298713)
95. Yarlett N., Garofalo J., Goldberg B., Ciminelli M. A., Ruggiero V., Sufrin J. R., Bacchi C. J., S-Adenosylmethionine synthetase in bloodstream Trypanosoma brucei Biochimica et Biophysica Acta 1993 1181 1 68 76 (Pubitemid 23087524)
96. Ghoda L., Wang C. C., Coffino P., Ornithine decarboxylase of African trypanosomes Biochemical Society Transactions 1990 18 5 739 740 (Pubitemid 20359285)
97. Iten M., Mett H., Evans A., Enyaru J. C., Brun R., Kaminsky R., Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L- -difluoromethylornithine Antimicrobial Agents and Chemotherapy 1997 41 9 1922 1925 (Pubitemid 27383228)
98. Henderson G. B., Fairlamb A. H., Trypanothione metabolism: a chemotherapeutic target in trypanosomatids Parasitology Today 1987 3 10 312 315 (Pubitemid 17147472)
99. Bellofatto V., Fairlamb A. H., Henderson G. B., Cross G. A., Biochemical changes associated with -difluoromethylornithine uptake and resistance in Trypanosoma brucei Molecular and Biochemical Parasitology 1987 25 3 227 238
100. Stewart M. L., Boussard C., Brun R., Gilbert I. H., Barrett M. P., Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter Antimicrobial Agents and Chemotherapy 2005 49 12 5169 5171 (Pubitemid 41778944)
101. Barrett M. P., Gilbert I. H., Targeting of toxic compounds to the Trypanosome's interior Advances in Parasitology 2006 63 125 183 (Pubitemid 44666967)
102. Hawkins R. A., O'Kane R. L., Simpson I. A., Via J. R., Structure of the blood-brain barrier and its role in the transport of amino acids Journal of Nutrition 2006 136 218S 226S (Pubitemid 43156512)
103. O'Kane R. L., Via J. R., Simpson I., Zaragoz R., Mokashi A., Hawkins R. A., Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y + American Journal of Physiology: Endocrinology and Metabolism 2006 291 2 E412 E419
104. Haegele K. D., Alken R. G., Grove J., Schechter P. J., Koch-Weser J., Kinetics of -difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase Clinical Pharmacology and Therapeutics 1981 30 2 210 217 (Pubitemid 12149141)
105. Phillips M. A., Coffino P., Wang C. C., Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition Journal of Biological Chemistry 1987 262 18 8721 8727 (Pubitemid 17102675)
106. Yun O., Priotto G., Tong J., Flevaud L., Chappuis F., NECT is next: implementing the new drug combination therapy for trypanosoma brucei gambiense sleeping sickness PLoS Neglected Tropical Diseases 2010 4 5, article e720
107. Wenzler T., Boykin D. W., Ismail M. A., Hall J. E., Tidwell R. R., Brun R., New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289 Antimicrobial Agents and Chemotherapy 2009 53 10 4185 4192
108. Hu L., Arafa R. K., Ismail M. A., Patel A., Munde M., Wilson W. D., Wenzler T., Brun R., Boykin D. W., Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum Bioorganic and Medicinal Chemistry 2009 17 18 6651 6658
109. Bakunov S. A., Bakunova S. M., Wenzler T., Ghebru M., Werbovetz K. A., Brun R., Tidwell R. R., Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3- triazoles Journal of Medicinal Chemistry 2010 53 1 254 272
110. Magez S., Caljon G., Tran T., Stijlemans B., Radwanska M., Current status of vaccination against African trypanosomiasis Parasitology 2010 137 14 2017 2027
111. Roditi I., Clayton C., An unambiguous nomenclature for the major surface glycoproteins of the procyclic form of Trypanosoma brucei Molecular and Biochemical Parasitology 1999 103 1 99 100 (Pubitemid 29428232)
112. Mehlert A., Zitzmann N., Richardson J. M., Treumann A., Ferguson M. A., The glycosylation of the variant surface glycoproteins and procyclic acidic repetitive proteins of Trypanosoma brucei Molecular and Biochemical Parasitology 1998 91 1 145 152 (Pubitemid 28242510)
113. El-Sayed N. M., Myler P. J., Blandin G., Berriman M., Crabtree J., Aggarwal G., Caler E., Renauld H., Worthey E. A., Hertz-Fowler C., Ghedin E., Peacock C., Bartholomeu D. C., Haas B. J., Tran A. N., Wortman J. R., Alsmark U. C. M., Angiuoli S., Anupama A., Badger J., Bringaud F., Cadag E., Carlton J. M., Cerqueira G. C., Creasy T., Delcher A. L., Djikeng A., Embley T. M., Hauser C., Ivens A. C., Kummerfeld S. K., Pereira-Leal J. B., Nilsson D., Peterson J., Salzberg S. L., Shallom J., Silva J. C., Sundaram J., Westenberger S., White O., Melville S. E., Donelson J. E., Andersson B., Stuart K. D., Hall N., Comparative genomics of trypanosomatid parasitic protozoa Science 2005 309 5733 404 409
114. Rudenko G., Epigenetics and transcriptional control in African trypanosomes Essays in Biochemistry 2010 48 1 201 219
115. Hong Y., Kinoshita T., Trypanosome glycosylphosphatidylinositol biosynthesis Korean Journal of Parasitology 2009 47 3 197 204
116. Maina N., Maina K. J., Mser P., Brun R., Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate Acta Tropica 2007 104 2-3 84 90 (Pubitemid 47592836)
117. Matthews K. R., The developmental cell biology of Trypanosoma brucei Journal of Cell Science 2005 118 2 283 290 (Pubitemid 40277341)
118. MacGregor P., Matthews K. R., New discoveries in the transmission biology of sleeping sickness parasites: applying the basics Journal of Molecular Medicine 2010 88 9 865 871
119. Field M. C., Carrington M., The trypanosome flagellar pocket Nature Reviews Microbiology 2009 7 11 775 786
120. Hutchinson O. C., Webb H., Picozzi K., Welburn S., Carrington M., Candidate protein selection for diagnostic markers of African trypanosomiasis Trends in Parasitology 2004 20 11 519 523 (Pubitemid 39313090)
121. Matthews H. B., Lucier G. W., Fisher K. D., Medicinal herbs in the United States: research needs Environmental Health Perspectives 1999 107 10 773 778 (Pubitemid 29525127)
122. Yeh G. Y., Eisenberg D. M., Kaptchuk T. J., Phillips R. S., Systematic review of herbs and dietary supplements for glycemic control in diabetes Diabetes Care 2003 26 4 1277 1294 (Pubitemid 36929285)
123. Hamdan I. I., Afifi F. U., Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine Journal of Ethnopharmacology 2004 93 1 117 121 (Pubitemid 38739281)
124. Rangasamy O., Raoelison G., Rakotoniriana F. E., Cheuk K., Urverg-Ratsimamanga S., Quetin-Leclercq J., Gurib-Fakim A., Subratty A. H., Screening for anti-infective properties of several medicinal plants of the Mauritians flora Journal of Ethnopharmacology 2007 109 2 331 337 (Pubitemid 44959703)
125. Mahomoodally M. F., Gurib-Fakim A., Subratty A. H., Antimicrobial activities and phytochemical profiles of endemic medicinal plants of Mauritius Pharmaceutical Biology 2005 43 3 237 242 (Pubitemid 40745451)
126. Mahomoodally M. F., Gurib-Fakim A., Subratty A. H., Screening for alternative antibiotics: an investigation into the antimicrobial activities of medicinal food plants of Mauritius Journal of Food Science 2010 75 3 M173 M177
127. Ranilla L. G., Kwon Y.-I., Apostolidis E., Shetty K., Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America Bioresource Technology 2010 101 12 4676 4689
128. Ravi Kumar A., Ponnusamy S., Ravindran R., Zinjarde S., Bhargava S., Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro Evidence-based Complementary and Alternative Medicine 2011 2011 10
129. WHO, WHO's Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines 1993 Regional Office for the Western Pacific
130. WHO, WHO expert committee on specifications for pharmaceutical preparations 2003 908 WHO Technical Report Series
131. WHO, Good manufacturing practices: updated supplementary guidelines for the manufacture of herbal medicines 2005 QAS/04.050/Rev.3 Geneva, Switzerland WHO
132. WHO, Prevention and control: a strategy for the who african region: report of the regional director Proceedings of the 57 Session August 2007 Brazzaville, Republic of Congo
133. Astin J. A., Why patients use alternative medicine: results of a national study Journal of the American Medical Association 1998 279 19 1548 1553 (Pubitemid 28233010)
134. Bent S., Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center Journal of General Internal Medicine 2008 23 6 854 859
135. Hostettmann K., Strategy for the biological and chemical evaluation of plant extracts Pure and Applied Chemistry 1998 70 11 1 9
136. Barrett B., Kiefer D., Rabago D., Assessing the risks and benefits of herbal medicine: an overview of scientific evidence Alternative Therapies in Health and Medicine 1999 5 4 40 49
137. Ang-Lee M. K., Moss J., Yuan C. S., Herbal medicines and perioperative care Journal of the American Medical Association 2001 286 2 208 216 (Pubitemid 32640852)
138. Vuksan V., Sievenpiper J. L., Xu Z., Wong E. Y., Jenkins A. L., Beljan-Zdravkovic U., Leiter L. A., Josse R. G., Stavro M. P., Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus Journal of the American College of Nutrition 2001 20 5 370S 380S (Pubitemid 32951814)
139. Patwardhan A., Gandhe R., Ghole V., Mourya D., Larvicidal activity of the fungus Aphanomyces (oomycetes: Saprolegniales) against Culex quinquefasciatus Journal of Communicable Diseases 2005 37 4 269 274 (Pubitemid 44971760)
140. Pieters L., Vlietinck A. J., Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds? Journal of Ethnopharmacology 2005 100 1-2 57 60 (Pubitemid 41073522)
141. Goldman P., Herbal medicines today and the roots of modern pharmacology Annals of Internal Medicine 2001 135 8 594 600 (Pubitemid 33010195)
142. Abdel-Sattar E., Shehab N. G., Ichino C., Kiyohara H., Ishiyama A., Otoguro K., Omura S., Yamada H., Antitrypanosomal activity of some pregnane glycosides isolated from Caralluma species Phytomedicine 2009 16 6-7 659 664
143. Abubakar A., Iliyasu B., Yusuf A. B., Antitrypanosomal and haematological effects of selected Nigerian medicinal plants in Wistar rats Biokemistri 2005 17 2 95 99
144. Abu A. H., Uchendu C. N., Ofukwu R. A., In vitro anti trypanosomal activity of crude extracts of some Nigerian medicinal plants Journal of Applied Biosciences 2009 21 1277 1282
145. Atawodi S. E., Bulus T., Ibrahim S., Ameh D. A., Nok A. J., Mamman M., Galadima M., In vitro trypanocidal effect of methanolic extract of some Nigerian savannah plants African Journal of Biotechnology 2003 2 9 317 321
146. Peter O., Magiri E., Auma J., Magoma G., Imbuga M., Murilla G., Evaluation of in vivo antitrypanosomal activity of selected medicinal plant extracts Journal of Medicinal Plant Research 2009 3 11 849 854
147. Orhue N. E. J., Nwanze E. A. C., Okafor A., Scoparia dulcis protects against Trypanosoma brucei induced immunosuppression in experimentally infected rabbits African Journal of Food Science 2009 3 6 172 175
148. Hussain H. S. N., Deeni Y. Y., Plants in Kano ethnomedicine; screening for antimicrobial activity and alkaloids International Journal of Pharmacognosy 1991 29 1 51 56
149. Cordell G. A., Quinn-Beattie M. L., Farnsworth N. R., The potential of alkaloids in drug discovery Phytotherapy Research 2001 15 3 183 205 (Pubitemid 32463303)
150. Mitscher L. A., Leu R. P., Bathala M. S., Wu W. N., Beal J. L., Antimicrobial agents from higher plants. I. Introduction, rationale, and methodology Lloydia 1972 35 2 157 166
151. Rojas A., Hernandez L., Pereda-Miranda R., Mata R., Screening for antimicrobial activity of crude drug extracts and pure natural products from Mexican medicinal plants Journal of Ethnopharmacology 1992 35 3 275 283
152. Atawodi S. E., Joy J. I., Uche S. N., Yusufu L., Phytochemical and antitrypanosomal studies of different solvents extracts of boswellia dalzielii International Journal of Biology 2011 3 2
153. Freiburghaus F., Kaminsky R., Nkunya M. H., Brun R., Evaluation of African medicinal plants for their in vitro trypanocidal activity Journal of Ethnopharmacology 1996 55 1 1 11 (Pubitemid 27051175)
154. Nibret E., Wink M., Volatile components of four Ethiopian Artemisia species extracts and their in vitro antitrypanosomal and cytotoxic activities Phytomedicine 2010 17 5 369 374
155. Nibret E., Ashour M. L., Rubanza C. D., Wink M., Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities Phytotherapy Research 2010 24 6 945 947
156. Adeyemi O. S., Akanji M. A., Oguntoye S. A., Ethanolic leaf extract of Psidium guajava: phytochemical and trypanocidal activity in rats infected with Trypanosoma brucei brucei Journal of Medicinal Plant Research 2009 3 5 420 423